1.0The Horsehttps://thehorse.comAmikacin Therapy in Newbornsrich600338<blockquote class="wp-embedded-content" data-secret="9fkYRWwIfd"><a href="https://thehorse.com/152564/amikacin-therapy-in-newborns/">Amikacin Therapy in Newborns</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://thehorse.com/152564/amikacin-therapy-in-newborns/embed/#?secret=9fkYRWwIfd" width="600" height="338" title="“Amikacin Therapy in Newborns” — The Horse" data-secret="9fkYRWwIfd" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
</script>
Aminoglycosides, including amikacin, are known for their potent activity against bacteria that cause sepsis in newborn foals. Dosage protocols for aminoglycosides have been extensively studied in humans, and conventional dosing at eight- to 12-hour intervals is now giving way to high-dose, once-daily administration. Human studies have shown that amikacin is more effective and less toxic to th